Counterpoint Mutual Funds LLC 10x Genomics, Inc. Transaction History
Counterpoint Mutual Funds LLC
- $753 Million
- Q4 2024
A detailed history of Counterpoint Mutual Funds LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Counterpoint Mutual Funds LLC holds 51,658 shares of TXG stock, worth $563,072. This represents 0.1% of its overall portfolio holdings.
Number of Shares
51,658Holding current value
$563,072% of portfolio
0.1%Shares
4 transactions
Others Institutions Holding TXG
# of Institutions
302Shares Held
96.5MCall Options Held
76.4KPut Options Held
132K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.9MShares$130 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$119 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$69.7 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.5.71MShares$62.3 Million0.92% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.5.71MShares$62.3 Million0.06% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.04B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...